Improving the Remission Quality in Acute Myelogenous Leukemia (AML) by Increasing Cytoreduction During Induction Therapy

1994 ◽  
pp. 231-234
Author(s):  
Z. A. Arlin ◽  
P. Cook ◽  
T. Ahmed ◽  
A. Mittelman ◽  
C. Puccio ◽  
...  
Keyword(s):  
Induction Therapy ◽  
Acute Myelogenous Leukemia ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

scholarly journals Dynamic Single-Cell Network Profiles in Acute Myelogenous Leukemia Are Associated with Patient Response to Standard Induction Therapy

2010 ◽  
Vol 16 (14) ◽  
pp. 3721-3733 ◽  
Author(s):  
Steven M. Kornblau ◽  
Mark D. Minden ◽  
David B. Rosen ◽  
Santosh Putta ◽  
Aileen Cohen ◽  
...  
Keyword(s):  
Single Cell ◽  
Induction Therapy ◽  
Acute Myelogenous Leukemia ◽  
Myelogenous Leukemia ◽  
Patient Response ◽  
Cell Network ◽  
Acute Myelogenous

scholarly journals DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia

2015 ◽  
Vol 21 (7) ◽  
pp. 1614-1620 ◽  
Author(s):  
Alison R. Sehgal ◽  
Phyllis A. Gimotty ◽  
Jianhua Zhao ◽  
Jing-Mei Hsu ◽  
Robert Daber ◽  
...  
Keyword(s):  
Induction Therapy ◽  
Acute Myelogenous Leukemia ◽  
Myelogenous Leukemia ◽  
Mutational Status ◽  
Acute Myelogenous

Amsacrine and Continuous-Infusion High-Dose Cytosine Arabinoside as Induction Therapy for Patients with Newly-Diagnosed Acute Myelogenous Leukemia

1996 ◽  
Vol 22 (1-2) ◽  
pp. 71-76 ◽  
Author(s):  
Habib M. Ghaddar ◽  
Sherry Pierce ◽  
Hagop M. Kantarjian ◽  
Emil J. Freireich ◽  
Michael J. Keating ◽  
...  
Keyword(s):  
Continuous Infusion ◽  
Induction Therapy ◽  
Cytosine Arabinoside ◽  
Acute Myelogenous Leukemia ◽  
Myelogenous Leukemia ◽  
High Dose ◽  
Newly Diagnosed ◽  
Acute Myelogenous
Sign in / Sign up

Export Citation Format

Share Document